Search Results for keywords:"controlled substances regulation"

The Drug Enforcement Administration (DEA) has announced that North Star Holdings California, LLC, has applied to become a registered bulk manufacturer of marihuana, a Schedule I controlled substance. This application is part of a DEA program that regulates the cultivation of marihuana for scientific and medical research purposes. The DEA will review this and similar applications to ensure compliance with relevant laws and regulations, ensuring that adequate measures are in place to prevent illegal distribution. Interested parties may submit comments or objections to the DEA regarding this application before April 19, 2021.

Mylan Pharmaceuticals Inc. has submitted an application to be recognized as an importer of controlled substances. The Drug Enforcement Administration (DEA), a part of the Justice Department, is providing notice of this application. Interested parties, such as other registered manufacturers or applicants, have the opportunity to submit written comments, objections, or requests for a hearing on this application by March 8, 2021. Comments and hearing requests should be sent to the DEA at their Springfield, Virginia address.